Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | University of Oxford |
| Country | United Kingdom |
| Start Date | Jul 01, 2021 |
| End Date | Dec 31, 2023 |
| Duration | 913 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 222119 |
There are an estimated 100-400 million cases of dengue worldwide per year with the highest burden of disease in Asia. The virus (DENV) is a positive-sense single stranded RNA virus belonging to the genus Flavivirus. There are four serotypes: DENV1 to DENV4.
Dengue virus RNA dependent RNA polymerase has no proof-reading activity, resulting in accumulation of mutations at each replication cycle.
Therefore, within an infected individual, there is diversification of the DENV genome sequence leading to the presence of intra-host genetic variants (quasispecies), which may then lead, under selective pressure, to the emergence of a new strain of higher virulence. Previous findings suggested that immune pressure drives intra-host diversity.
My research will explore whether serotype-specific past immunity influences intra-host DENV genetic diversity during acute infection.
Objectives: - To describe intra host DENV genetic diversity in patients with primary and secondary infections - To compare quasispecies profiles between primary and secondary infections - To compare quasispecies profiles in secondary infections between two patient groups previously exposed to a different serotype.
Impact : We expect the findings of this project would permit a better understanding of processes leading to viral genetic variation, and could eventually be useful for improving viral surveillance systems and epidemic forecasting.
University of Oxford
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant